JP6912763B2 - カテキンの機能性増強法 - Google Patents

カテキンの機能性増強法 Download PDF

Info

Publication number
JP6912763B2
JP6912763B2 JP2016529649A JP2016529649A JP6912763B2 JP 6912763 B2 JP6912763 B2 JP 6912763B2 JP 2016529649 A JP2016529649 A JP 2016529649A JP 2016529649 A JP2016529649 A JP 2016529649A JP 6912763 B2 JP6912763 B2 JP 6912763B2
Authority
JP
Japan
Prior art keywords
eriodictyol
effect
egcg
action
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016529649A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2015199169A1 (ja
Inventor
立花　宏文
宏文 立花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyushu University NUC
Original Assignee
Kyushu University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54938246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6912763(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyushu University NUC filed Critical Kyushu University NUC
Publication of JPWO2015199169A1 publication Critical patent/JPWO2015199169A1/ja
Application granted granted Critical
Publication of JP6912763B2 publication Critical patent/JP6912763B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
JP2016529649A 2014-06-27 2015-06-25 カテキンの機能性増強法 Active JP6912763B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014132891 2014-06-27
JP2014132891 2014-06-27
PCT/JP2015/068302 WO2015199169A1 (ja) 2014-06-27 2015-06-25 カテキンの機能性増強法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020068670A Division JP2020121990A (ja) 2014-06-27 2020-04-06 カテキンの機能性増強法

Publications (2)

Publication Number Publication Date
JPWO2015199169A1 JPWO2015199169A1 (ja) 2017-05-25
JP6912763B2 true JP6912763B2 (ja) 2021-08-04

Family

ID=54938246

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016529649A Active JP6912763B2 (ja) 2014-06-27 2015-06-25 カテキンの機能性増強法
JP2020068670A Pending JP2020121990A (ja) 2014-06-27 2020-04-06 カテキンの機能性増強法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020068670A Pending JP2020121990A (ja) 2014-06-27 2020-04-06 カテキンの機能性増強法

Country Status (3)

Country Link
US (1) US10251408B2 (enExample)
JP (2) JP6912763B2 (enExample)
WO (1) WO2015199169A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6912763B2 (ja) * 2014-06-27 2021-08-04 国立大学法人九州大学 カテキンの機能性増強法
JP6881890B2 (ja) * 2015-05-14 2021-06-02 花王株式会社 カテキン類吸収促進剤
CN109152931A (zh) * 2016-03-28 2019-01-04 可口可乐公司 具有类黄酮的甜菊醇糖苷或罗汉果苷甜味剂的甜度和味道改善
JP7061303B2 (ja) 2016-08-10 2022-04-28 国立大学法人九州大学 ６７ｋＤａラミニンレセプター活性化剤及びその使用
FR3061021B1 (fr) * 2016-12-23 2020-04-03 Etablissement Francais Du Sang Antagoniste specifique de tlr4 dans le traitement du myelome multiple
KR102428987B1 (ko) * 2017-05-16 2022-08-04 (주)아모레퍼시픽 차나무의 추출물을 함유하는 조성물
KR20190047873A (ko) 2017-10-30 2019-05-09 (주)아모레퍼시픽 특정 성분 함량이 증가된 차 추출물을 포함하는 지방대사 이상의 예방 및 개선용 조성물
JP2019151568A (ja) * 2018-03-01 2019-09-12 アサヒ飲料株式会社 酸性スフィンゴミエリナーゼ活性向上剤、酸性スフィンゴミエリナーゼ活性向上用組成物、及び抗アレルギー用組成物
WO2020096299A1 (ko) * 2018-11-05 2020-05-14 (주)아모레퍼시픽 성분 함량이 변화된 녹차 추출물, 및 이를 포함하는 조성물
JP7364497B2 (ja) 2020-03-04 2023-10-18 トヨタ自動車株式会社 緑茶抽出物含有組成物、機能性食品
JP2022092966A (ja) * 2020-12-11 2022-06-23 トヨタ自動車株式会社 ジペプチジルペプチダーゼｉｖ阻害剤、機能性表示食品
EP4284355A1 (en) * 2021-01-28 2023-12-06 Abbott Laboratories Methods and nutritional compositions for improving muscle energy production and/or strength
JP2023008374A (ja) * 2021-07-06 2023-01-19 トヨタ自動車株式会社 抗肥満剤用組成物、機能性食品
CN114990169B (zh) * 2022-06-16 2023-07-28 中国农业科学院茶叶研究所 一种制备EGCG-3”-Me的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
DE69924240T2 (de) 1999-06-23 2006-02-09 ICT Integrated Circuit Testing Gesellschaft für Halbleiterprüftechnik mbH Ladungsträgerteilchenstrahlvorrichtung
EP1123304B1 (en) * 1999-08-19 2003-10-08 Korea Research Institute of Bioscience and Biotechnology Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
JP4246980B2 (ja) * 2001-09-11 2009-04-02 花王株式会社 皮膚外用剤
JP2004075619A (ja) * 2002-08-20 2004-03-11 Naris Cosmetics Co Ltd タイプ２ヘルパーｔ細胞型サイトカイン抑制剤
JP2005075805A (ja) * 2003-09-03 2005-03-24 Kyoto Univ 酵素阻害剤
US20110274680A1 (en) * 2009-10-02 2011-11-10 Mazed Mohammad A Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
JP5517421B2 (ja) * 2007-08-03 2014-06-11 花王株式会社 容器詰飲料
JP6912763B2 (ja) * 2014-06-27 2021-08-04 国立大学法人九州大学 カテキンの機能性増強法

Also Published As

Publication number Publication date
JPWO2015199169A1 (ja) 2017-05-25
JP2020121990A (ja) 2020-08-13
WO2015199169A1 (ja) 2015-12-30
US20170156361A1 (en) 2017-06-08
US10251408B2 (en) 2019-04-09

Similar Documents

Publication Publication Date Title
JP6912763B2 (ja) カテキンの機能性増強法
Kim et al. Apigetrin induces extrinsic apoptosis, autophagy and G2/M phase cell cycle arrest through PI3K/AKT/mTOR pathway in AGS human gastric cancer cell
Wang et al. Naringenin prevents ischaemic stroke damage via anti‐apoptotic and anti‐oxidant effects
Yo et al. Licorice and licochalcone-A induce autophagy in LNCaP prostate cancer cells by suppression of Bcl-2 expression and the mTOR pathway
Li et al. Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer
Demir et al. Selective cytotoxic effect of Rhododendron luteum extract on human colon and liver cancer cells
Yang et al. Inhibitory effects of cocoa tea (Camellia ptilophylla) in human hepatocellular carcinoma HepG2 in vitro and in vivo through apoptosis
Rao et al. Strychnos nux-vomica root extract induces apoptosis in the human multiple myeloma cell line—U266B1
Kang et al. Sappanone A protects mice against cisplatin-induced kidney injury
EP3824898A1 (en) Dehydrated extracts based phyto complex comprising citrus bergamia and its pharmaceutical use
Parisotto et al. The antitumor activity of extracts from Cordia verbenacea DC obtained by supercritical fluid extraction
Kou et al. Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling
Kim et al. The extract of the immature fruit of Poncirus trifoliata induces apoptosis in colorectal cancer cells via mitochondrial autophagy
Gorlach et al. Polyphenols from evening primrose (Oenothera paradoxa) defatted seeds induce apoptosis in human colon cancer Caco-2 cells
Khatibi et al. In vitro evaluation of cytotoxic and antiproliferative effects of Portulaca oleracea ethanolic extracton on hela cell line
Nagai et al. Anti-obesity effects of Asian dayflower, Commelina communis, in mice with high-fat diet-induced obesity and in 3T3-L1 cells
KR101959731B1 (ko) 새싹보리 추출물을 포함하는 갱년기 장애의 예방 또는 치료용 조성물
Murugaiyah et al. Lipid-lowering effect of hydroalcoholic extracts of Gynura procumbens in Chemical-and High-fat diet-induced hyperlipidemic rats
KR101917363B1 (ko) 콩 발아배아 추출물을 포함하는 여성 갱년기 질환의 예방 또는 치료용 약학조성물
JP7364497B2 (ja) 緑茶抽出物含有組成物、機能性食品
KR101387970B1 (ko) 암 예방 및 치료용 조성물 및 건강기능식품
KR102040119B1 (ko) 신선초 추출물로부터 분리된 화합물을 함유하는 근육관련 질환의 예방 및 치료용 조성물
KR101655554B1 (ko) 택사 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 포함하는 골질환의 예방 또는 치료용 약학적 조성물
ÖNER et al. Novel Natural Compounds for Hepatocellular Carcinoma Treatment
Li et al. Study on the influence of curcumin on chemosensitivity of nephroblastoma cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180612

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190718

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200406

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200406

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20200421

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200521

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20200526

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20200821

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20200825

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20201222

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20210224

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210413

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210423

C302 Record of communication

Free format text: JAPANESE INTERMEDIATE CODE: C302

Effective date: 20210423

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210518

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210615

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210629

R150 Certificate of patent or registration of utility model

Ref document number: 6912763

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R157 Certificate of patent or utility model (correction)

Free format text: JAPANESE INTERMEDIATE CODE: R157

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250